Common Shares Outstanding: The number of class A shares currently held by investors.
Oncotelic Therapeutics, Inc. (OTLC) had Common Shares Outstanding of 457.01M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$0.25M |
|
$0.39M |
|
-- |
|
$0.25M |
|
$1.09M |
|
$-0.84M |
|
$1.18M |
|
$0.34M |
|
$-1.06M |
|
$0.34M |
|
$0.34M |
|
$0.34M |
|
$-1.06M |
|
$-0.84M |
|
$-0.69M |
|
447.39M |
|
467.91M |
|
$0.00 |
|
$0.00 |
|
| Balance Sheet Financials | |
$1.46M |
|
-- |
|
$393.29M |
|
$394.75M |
|
$17.91M |
|
$1.85M |
|
$113.40M |
|
$131.31M |
|
$263.44M |
|
$260.65M |
|
$263.44M |
|
|
Common Shares Outstanding |
457.01M |
| Cash Flow Statement Financials | |
$-0.43M |
|
-- |
|
$0.53M |
|
$0.11M |
|
$0.21M |
|
$0.10M |
|
$2.50M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.08 |
|
-- |
|
-- |
|
0.01 |
|
0.05 |
|
100.00% |
|
-337.43% |
|
-337.43% |
|
-- |
|
136.40% |
|
155.26% |
|
$-0.43M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
121.48 |
|
0.74 |
|
0.13% |
|
0.13% |
|
0.09% |
|
0.13% |
|
$0.58 |
|
$-0.00 |
|
$-0.00 |
|